23 Jun
2017
12:47 E.S.T.

Calyxt Files Registration Statement for Proposed Initial Public Offering

Read more

09 Jun
2017
16:30 E.S.T.

Annual General Meeting of June 26, 2017

Read more

10 May
2017
16:30 E.S.T.

Cellectis Patent Encompassing Broad Uses of Gene Editing Technologies Maintained by USPTO

Read more

09 May
2017
16:30 E.S.T.

Cellectis Reports 1st Quarter 2017 Financial Results

Read more

27 Apr
2017
16:30 E.S.T.

Cellectis CEO Selected as Speaker for 2017 Milken Institute Global Conference

Read more

25 Apr
2017
16:30 E.S.T.

Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting

Read more

12 Apr
2017
16:30 E.S.T.

Cellectis S.A. to Explore Possible Initial Public Offering of Calyxt, Inc.

Read more

31 Mar
2017
16:30 E.S.T.

Cellectis to Present at the 2017 Annual Conference of the American Association for Cancer Research

Read more

09 Mar
2017
16:30 E.S.T.

Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia

Read more

07 Mar
2017
16:30 E.S.T.

Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board

Read more